ECOG, ACRIN Join Forces

Article

The American College of Radiology Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG) today unveiled their clinical research alliance: ECOG-ACRIN Cancer Research Group (ECOG-ACRIN).

The American College of Radiology Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG) today unveiled their clinical research alliance: ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). 

“We are already actively engaged in the shared mission of reshaping the future of patient care through clinical research that leads to earlier cancer detection, more successful therapeutic intervention, greater rates of prevention, and more successful patient outcomes,” officials of the alliance said at the 2011 ACRIN Annual Meeting on Friday. They said their two respective National Cancer Institute cooperative groups have merged their oncology research activities into three core areas of emphasis:

• Early detection and diagnosis of cancer;

• Biomarker-driven Phase II and Phase III therapeutic studies for multiple cancer types and stages; and

• Genetic, molecular and imaging marker research to predict and monitor treatment response.

The organizations seek “bold integration of disciplines and technologies,” with an eye toward conducting “definitive, groundbreaking, biomarker-driven clinical research that promises to achieve patient-centered breakthroughs.”

Integration efforts are afoot and the group’s leadership is developing the business, administrative, and scientific framework for ECOG-ACRIN to sustain and streamline its combined research portfolio through public and private support, ECOG-ACRIN officials said.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.